The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 915-926

  Levitsky, Victor ^a   Zhang, Qian Jin ^a   Levitskaya, Jelena ^a   Masucci, Maria G ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPITOPE; HLA ANTIGEN; PHYTOHEMAGGLUTININ;

ANTIGEN PRESENTATION; ARTICLE; CELL CLONING; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HLA SYSTEM; IMMUNOGENICITY; LIFESPAN; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BINDING, COMPETITIVE; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029920909     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.915     Document Type: Article

References (45)

1. Townsend, A.R.M., J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:959-968.
2. Jardetzky, T., W. Lane, R. Robinson, D. Madden, and D. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature (Lond.). 353:326-329.
3. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351:290-296.
4. Adorini, L., E. Appella, G. Doria, and Z.A. Nagy 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168:2091-2104.
5. Berzowsky, J.A. 1988. Immunodominance in T cell recognition Immunol. Lett. 18:83-92.
6. Mamula, M.J. 1993. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177.567-571.
7. Dick, L.R., C. Aldrich, S.C. Jameson, C.R. Moomaw, B.C. Pramanik, C.K. Doyle, G.N. DeMartino, M.J. Bevan, J.M. Forman, and C.A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884-3894.
8. Neidermann, G., S. Butz, H.G. Iheinfeldt, H. Hoschützky, G. Jung, B. Maier, and K. Eichman. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility class I molecules. Immunity. 2:289-299.
9. Wettstein, P.J., G.M. van Bleek, and S.G. Nathenson. 1993. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responses. J. Immunol. 150:2753-2760.
10. Chen, W., S. Khilko, J. Fecondo, D.H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-pepride affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471-1483.
11. Kubo, R.T., A. Sette, H.M. Grey, E. Appella, K. Sakaguchi, N.Z. Zhu, D. Arnott, N. Sherman, J. Shabanowutz, H. Michel, et al. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913-3924.
12. Kast, W.M., R.M.P. Brandt, J. Sidney, J.W. Drijfhout, R. Kubo, H. Grey, C.J.M. Melief, and A. Sette. 1994. Role of HLA A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904-3912.
13. Heemels, M.T., T.N.M. Schumacher, K. Wonigheit, and H.L. Ploegh. 1993. Peptide translocation by variants of the transporter associated with antigen processing. Science (Wash. DC). 262:2059-2063.
14. Shepherd, J.C., T.N.M. Shumacher, P.G. Ashton-Rickard, S. Imaeda, H.L. Ploegh, H.L. Janewey, and S. Tonegawa. 1993. TAP-1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell. 74:577-584.
15. Masucci, M.G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends in Microbiology. 2:125-130.
16. Rickinson, A.B., M. Rowe, I.J. Hart, Q.Y. Yao, L.E. Henderson, H. Rabin, and M.A. Epstein. 1984. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B cell transformation in vitro: studies with cyclosporin A. Cell. Immunol. 87:646-658.
17. Crawford, D.H., J.A. Thomas, G. Janosy, P. Sweney, O.N. Fernando, J.F. Moorhead, and J.H. Thompson. 1980. Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patients with renal allograft. Lancet. (i):1355-1356.
18. Thomas, J., M. Allday, and D. Crawford. 1991. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv. Cancer Res. 57:329-380.
19. Wallace, L., and R. Murray. 1989. Immunological aspects of the EBV system. In Advances in Viral Oncology. G. Klein, editor. Raven Press, New York. 219-236.
20. de Campos-Lima, P.O., V. Levitsky, J. Brooks, S.P. Lee. L.F. Hu, A.B. Rickinson, and M.G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes In Epstein-Barr virus isolated from highly A11-positive populations by selective mutations of anchor residues. J. Exp. Med. 179:1297-1305.
21. Gavioli, R., M. Kurilla, P.-O. de Campos-Lima, L.E. Wallace, R. Dolcetti, R.J. Murray, A.B. Rickinson, and M.G. Masucci. 1993. Multiple HLA A11 restricted CTL epitopes of different immunogenicity in the Epstein-Barr virus (EBV) encoded nuclear antigen-4 (EBNA4). J. Virol. 67:1572-1578.
22. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:190-194.
23. Hirs, C., and S. Timasheff. 1977. Methods of peptide synthesis. In Enzyme structure. Academic Press, New York. XLVII. 501-617.
24. Dumas, B. 1975. Standards for total serum protein assays, a collaborative study. Clin. Chem. 21:1159-1166.
25. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
26. Towbin, H.T., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
27. Neefjes, J., F. Momburg, and G.J. Hämmerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science (Wash DC). 261:769-771.
28. Salter, R., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant T X B cell hybrid. EMBO (Eur. Mol. Biol. Organ.) J. 5:943-949.
29. Zhang, Q.-J., R. Gavioli, G. Klein, and M.G. Masucci. 1993. An HLA A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sci. USA. 90:2217-2221.
30. Barnstable, C., W. Bodmer, G. Brown, G. Galfre, C. Milstein, A. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other cell surface antigens. New tools for generic analysis. Cell. 14: 9-20.
31. Neefjes, J., B. Breur-Vrisendorp, G. van Seventer, P. Ivany, and H. Ploegh. 1986. An improved biochemical method for analysis of HLA class I antigens. Hum. Immunol. 16:169-181.
32. Torsteinsdottir, S., M.G. Masucci, B. Ehlin-Henriksson, C. Brautbar, H. Ben Bassat, G. Klein, and E. Klein. 1986. Differentiation dependent sensitivity of human B-cell derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc. Natl. Acad. Sci. USA. 83:5620-5624.
33. Rabin, H., R.F. Hopkins, F.W. Ruscetti, R.H. Neubawer, R.L. Brown, and T.G. Kawakami. 1981. Spontaneous release of a factor with properties of T-cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127: 1852-1856.
34. Rammensee, H.G., O. Rötzschke, and K. Falk. 1993. MHC class I-restricted antigen processing - lesson from natural ligands. Chem. Immunol. 57:113-120.
35. + cytotoxic T lymphocytes in association with class I MHC proteins. Cell. 69:989-998.
36. + T-cell clones. Proc. Natl. Acad. Sci. USA. 90:11272-11276.
37. Tsomides, T.J., A. Aldovini, R.P. Johnson, B.D. Walker, R.A. Young, and H.N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
38. Falk, K., O. Rötzschke, K. Deres, J. Metzger, G. Jung, and H.G. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425-434.
39. Palmer, E.G. 1994. Direct sequence identification and kinetic analysis of an MHC class I restricted Lysteria monocytogenes CTL epitope. J. Immunol. 152:686-694.
40. Ruppert, J., J. Sidney, E. Celis, R.T. Kubo, H.M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA A2.1 molecules. Cell. 74;929:937.
41. Townsend, A., T. Elliott, V. Cerundolo, L. Foster, B. Barber, and A. Tse. 1990. Assembly of MHC class I molecules analyzed in vitro. Cell. 62:285-292.
42. Parker, K.C., M.A. Bednarek, and J.E. Coligan. 1994. Scheme for ranking potential HLA A2 binding peptides based on independent binding of individual peptide side chains. J. Immunol. 152:163-175.
43. Nelson, C.A., S.J. Petzold, and E.R. Unanue. 1994. Peptide determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature (Lond.). 371:250-252.
44. Reid, P.A., and C. Watts. 1990. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature (Lond.). 346:655-657.
45. Diment, S., and P. Stahl. 1985. Macrophage endosomes contain proteases which degrade endocytosed protein ligands. J. Biol. Chem. 260:1531-1541.